Monte Rosa Therapeutics Inc (GLUE)

Monte Rosa Therapeutics Inc Azioni (GLUE) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	1.064	-	-	-	-
Operating Expenses	3.29% 36.01	34.86	36.97	37.22	34.26
Benefits Costs and Expenses	32.95	-	-	-	-
Costs And Expenses	32.95	-	-	-	-
Operating Income/Loss	0.24% -34.95	-34.86	-36.97	-37.22	-34.26
Nonoperating Income/Loss	92.70% 3.062	1.589	2.254	2.233	2.221
Income/Loss From Continuing Operations Before Tax	4.17% -31.89	-33.27	-34.71	-34.99	-32.04
Income Tax Expense/Benefit	477.27% 0.083	-0.022	0.17	0.19	-
Income/Loss From Continuing Operations After Tax	3.86% -31.97	-33.25	-34.88	-35.18	-32.04
Net Income/Loss	3.86% -31.97	-33.25	-34.88	-35.18	-32.04
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,128% 60.16	1.8638	49.81	49.43	49.35
Diluted Average Shares	3,128% 60.16	1.8638	49.81	49.43	49.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-